Fig. 1From: The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptinSchematic depicts the cardiovascular protective effects of linagliptin based on pre-clinical and clinical evidenceBack to article page